Lost opportunity to save newborn lives: variable national antenatal screening policies for Neisseria gonorrhoeae and Chlamydia trachomatis

International Journal of STD and AIDS

Volumn 28, Issue 7, 2017, Pages 660-666

  Medline, Alexandra ^a   Joseph Davey, Dvora ^b,c   Klausner, Jeffrey D ^b  

^a Department of Medicine   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chlamydia (Chlamydia trachomatis); gonorrhea (Neisseria gonorrhoeae); prevention; screening; women

Indexed keywords

ADULT; ARTICLE; AUSTRALIA; BAHAMAS; BULGARIA; CANADA; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; ESTONIA; FEMALE; GERMANY; GONORRHEA; GROUPS BY AGE; HEALTH CARE POLICY; HIGH RISK PREGNANCY; HUMAN; JAPAN; LATVIA; MAJOR CLINICAL STUDY; NEISSERIA GONORRHOEAE; NEW ZEALAND; NEWBORN; NEWBORN INFECTION; NONHUMAN; NORTH KOREA; PREGNANT WOMAN; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; ROMANIA; SWEDEN; UNITED KINGDOM; UNITED STATES; WORLD HEALTH ORGANIZATION; ADOLESCENT; ISOLATION AND PURIFICATION; PREGNANCY; PREGNANCY COMPLICATION; PROCEDURES; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; GONORRHEA; HEALTH POLICY; HUMANS; INFANT, NEWBORN; NEISSERIA GONORRHOEAE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL DIAGNOSIS; RISK FACTORS; YOUNG ADULT;

EID: 85003897872     PISSN: 09564624     EISSN: 17581052     Source Type: Journal    
DOI: 10.1177/0956462416660483     Document Type: Article

References (44)

1. World Health Organization. Sexually transmitted infections (STIs) fact sheet. Updated December 2015, http://www.who.int/mediacentre/factsheets/fs110/en/ (accessed 16 February 2016)
2. Newman L. Global estimates of syphilis in pregnancy and associated adverse outcomes: analysis of multinational antenatal surveillance data. PLoS Med 2013; 10: e1001396–e1001396.
3. Rours GI. Chlamydia trachomatis infection during pregnancy associated with preterm delivery: a population-based prospective cohort study. Eur J Epidemiol 2011; 26: 493–502.
4. Peuchant O. Screening for Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium should it be integrated into routine pregnancy care in French young pregnant women? Diagn Microbiol Infect Dis 2015; 82: 14–19.
5. McMillan HM. Screening for Chlamydia trachomatis in asymptomatic women attending outpatient clinics in a large maternity hospital in Dublin, Ireland. Sex Transm Infect 2006; 82: 503–505.
6. World Health Organization. Guidelines for the management of sexually transmitted infections. http://apps.who.int/medicinedocs/en/d/Jh2942e/2.4.html#Jh2942e (2004, accessed 16 February 2016)
7. Centers for Disease Control and Prevention. Chlamydia – CDC fact sheet (detailed). Updated 17 November, http://www.cdc.gov/std/chlamydia/stdfact-chlamydia-detailed.htm (2015, accessed 16 February 2016)
8. Mullick S, Watson-Jones D, Beksinska M. Sexually transmitted infections in pregnancy: prevalence, impact on pregnancy outcomes, and approach to treatment in developing countries. Sex Transm Infect 2005; 81: 294–302.
9. Moore DL, MacDonald NE. Preventing ophthalmia neonatorum. Can J Infect Dis Med Microbiol 2015; 26: 122–125.
10. Bébéar C, de Barbeyrac B. Genital Chlamydia trachomatis infections. Clin Microbiol Infect 2009; 15: 4–10.
11. Lacey CJ, Milne JD. Preterm labour in association with Neisseria gonorrhoeae: case reports. Br J Vener Dis 1984; 60: 123–124.
12. Institute of Medicine (US) Committee on Improving Birth Outcomes; Bale JR, Stoll BJ, Lucas AO (eds) Improving birth outcomes: meeting the challenge in the developing world. Washington, DC: National Academies Press (US), 2003; The problem of low birth weight, http://www.ncbi.nlm.nih.gov/books/NBK222095/ (accessed 1 June 2016)
13. Adachi K, Nielsen-Saines K and Klausner JD. Chlamydia trachomatis infection in pregnancy: the global challenge of preventing adverse pregnancy and infant outcomes in sub-Saharan Africa and Asia. BioMed Res Int 2016; 2016: 9315757
14. Folger AT. Maternal Chlamydia trachomatis infections and preterm birth: the impact of early detection and eradication during pregnancy. Matern Child Health J 2014; 18: 1795–1802.
15. Adachi K. Chlamydia and NG in HIV-infected pregnant women and infant HIV transmission. Sex Transm Dis 2015; 42: 554–565.
16. Ghys PD, Fransen K, Diallo MO. The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Côte d’Ivoire. AIDS 1997; 11: F85–F93.
17. Centers for Disease Control and Prevention (CDC). Chlamydia trachomatis genital infections—United States, 1995. MMWR Morb Mortal Wkly Rep 1997; 46: 193–198.
18. Brocklehurst P and Rooney G. Interventions for treating genital Chlamydia trachomatis infection in pregnancy. Cochrane Database Syst Rev 1998; 4. Art. No.: CD000054
19. Beem MO, Saxon EM. Respiratory-tract colonization and a distinctive pneumonia syndrome in infants infected with Chlamydia trachomatis. N Engl J Med 1977; 296: 306–310.
20. Bilardi JE. Young pregnant women’s views on the acceptability of screening for chlamydia as part of routine antenatal care. BMC Public Health 2010; 10: 505–505.
21. Wynn A, Ramogola-Masire D, Gaolebale P, et al. Acceptability and feasibility of sexually transmitted infection testing and treatment among pregnant women in Gaborone, Botswana, 2015. BioMed Res Int 2016; 2016: Article 1251238
22. Pereboom MT. Knowledge and acceptability of Chlamydia trachomatis screening among pregnant women and their partners; a cross-sectional study. BMC Public Health 2014; 14: 704–704.
23. Cabeza J. Feasibility of Chlamydia trachomatis screening and treatment in pregnant women in Lima, Peru: a prospective study in two large urban hospitals. Sex Transm Infect 2015; 91: 7–10.
24. Alzahrani AJ. Screening of pregnant women attending the antenatal care clinic of a tertiary hospital in eastern Saudi Arabia for Chlamydia trachomatis and Neisseria gonorrhoeae infections. Indian J Sex Transm Dis 2010; 31: 81–86.
25. Ong JJ. Chlamydia screening for pregnant women aged 16–25 years attending an antenatal service: a cost-effectiveness study. BJOG 2015; 123: 1194–1202.
26. USPSTF recommendations for STI screening. U.S. Preventive Services Task Force. http://www.uspreventiveservicestaskforce.org/Page/Name/uspstf-recommendations-for-sti-screening (accessed 1 June 2016)
27. Blatt AJ, Lieberman JM, Hoover DR. Chlamydial and gonococcal testing during pregnancy in the United States. Am J Obstet Gynecol 2012; 207: 55.e1–55.e18.
28. Fontenot HB, George ER. Sexually transmitted infections in pregnancy. Nurs Womens Health 2014; 18: 67–72.
29. Wise MR. Chlamydia trachomatis screening in pregnancy in New Zealand: translation of national guidelines into practice. J Prim Health Care 2015; 7: 65–70.
30. Romoren M. Chlamydia and gonorrhoea in pregnant Batswana women: time to discard the syndromic approach? BMC Infect Dis 2007; 7: 27–27.
31. Chen XS. Sexually transmitted infections among pregnant women attending an antenatal clinic in Fuzhou, China. Sex Transm Dis 2006; 33: 296–301.
32. Paavonen J, Puolakkainen M, Paukku M. Cost-benefit analysis of first-void urine Chlamydia trachomatis screening program. Obstet Gynecol 1998; 92: 292–298.
33. Genc M, Mardh PA. Cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women. Ann Intern Med 1996; 124: 1–7.
34. Gottlieb SL. Toward global prevention of sexually transmitted infections (STIs): the need for STI vaccines. Vaccine 2014; 32: 1527–1535.
35. Moodley D. High prevalence and incidence of asymptomatic sexually transmitted infections during pregnancy and postdelivery in KwaZulu Natal, South Africa. Sex Transm Dis 2015; 42: 43–47.
36. Mbu ER. Gynaecological morbidity among HIV positive pregnant women in Cameroon. Reprod Health 2008; 5: 3–3.
37. Kohli R. Prevalence of genital chlamydia infection in urban women of reproductive age, Nairobi, Kenya. BMC Res Notes 2013; 6: 44–44.
38. Menendez C. Prevalence and risk factors of sexually transmitted infections and cervical neoplasia in women from a rural area of southern Mozambique. Infect Dis Obstet Gynecol 2010; 2010: Article 609315–Article 609315.
39. Wangnapi RA. Prevalence and risk factors for Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis infection in pregnant women in Papua New Guinea. Sex Transm Infect 2015; 91: 194–200.
40. Hokororo A. High prevalence of sexually transmitted infections in pregnant adolescent girls in Tanzania: a multi-community cross-sectional study. Sex Transm Infect 2015; 91: 473–478.
41. Joseph-Davey DL. Prevalence of curable sexually transmitted infections in pregnant women in low- and middle-income countries from 2010–2015: a systematic review. Sex Transm Dis 2016; 43: 450–458.
42. Mahilum-Tapay L. New point of care Chlamydia rapid test—bridging the gap between diagnosis and treatment: performance evaluation study. BMJ 2007; 335: 1190–1194.
43. Postma MJ, Bakker A, Welte R. [Screening for asymptomatic Chlamydia trachomatis infection in pregnancy; cost-effectiveness favorable at a minimum prevalence rate of 3% or more.]. Ned Tijdschr Geneeskd 2000; 144: 2350–2354.
44. Wheelahan D. Sexual Health Study in PNG set to improve maternal and newborn health. The Kirby Institute at UNSW and PNGIMR, http://newsroom.unsw.edu.au/news/health/sexual-health-study-png-set-improve-maternal-and-newborn-health (2015, accessed 15 March 2016)